SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-05-02 12:16
Tx date 2024-04-29 		$APLI
Appili Therapeutics Inc. 		Howling, Kenneth George
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$17,500
+437,500 vol
$0.04 each 		1,025,000
Filed 2024-05-02 00:07
Tx date 2024-04-29 		$APLI
Appili Therapeutics Inc. 		gowd, prakash
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$17,680
+442,000 vol
$0.04 each 		582,000
Filed 2024-05-01 23:58
Tx date 2024-04-29 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options 		$5,600
+140,000 vol
$0.04 each 		280,000
Filed 2024-05-01 23:54
Tx date 2024-04-29 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$22,200
+555,000 vol
$0.04 each 		1,236,300
Filed 2024-05-01 23:51
Tx date 2024-04-29 		$APLI
Appili Therapeutics Inc. 		Cilla, Donald
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$17,500
+437,500 vol
$0.04 each 		1,637,500
Filed 2024-05-01 23:43
Tx date 2024-04-29 		$APLI
Appili Therapeutics Inc. 		Balboni, Armand
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$8,000
+200,000 vol
$0.04 each 		2,893,000
Filed 2024-05-01 23:38
Tx date 2024-04-29 		$APLI
Appili Therapeutics Inc. 		Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$17,680
+442,000 vol
$0.04 each 		1,139,500
Filed 2023-11-17 12:12
Tx date 2023-11-15 		$APLI
Appili Therapeutics Inc. 		gowd, prakash
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+140,000 vol 		140,000
Filed 2023-11-17 12:10
Tx date 2023-11-13 		$APLI
Appili Therapeutics Inc. 		gowd, prakash
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-06-12 09:08
Tx date 2023-05-15 		$APLI
Appili Therapeutics Inc. 		Balboni, Armand
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+975,000 vol 		2,693,000
Filed 2023-06-12 09:05
Tx date 2023-05-15 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+140,000 vol 		140,000
Filed 2023-06-12 09:04
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-06-01 18:47
Tx date 2023-05-15 		$APLI
Appili Therapeutics Inc. 		Cilla, Donald
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+850,000 vol 		1,200,000
Filed 2023-06-01 18:29
Tx date 2023-05-15 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+565,000 vol 		681,300
Filed 2023-06-01 18:03
Tx date 2023-05-15 		$APLI
Appili Therapeutics Inc. 		Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+365,000 vol 		610,000
Filed 2023-06-01 18:01
Tx date 2023-05-15 		$APLI
Appili Therapeutics Inc. 		Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+452,500 vol 		697,500
Filed 2023-06-01 14:46
Tx date 2023-05-15 		$APLI
Appili Therapeutics Inc. 		Howling, Kenneth George
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+437,500 vol 		587,500
Filed 2023-05-30 18:23
Tx date 2023-05-08 		$APLI
Appili Therapeutics Inc. 		Cilla, Donald
4 - Director of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$3,000
+75,000 vol
$0.04 each 		75,000
Filed 2023-05-30 18:22
Tx date 2020-11-01 		$APLI
Appili Therapeutics Inc. 		Cilla, Donald
4 - Director of Issuer
Direct Ownership
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-01-12 14:02
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Cilla, Donald
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-488,000
-400,000 vol
$1.22 each 		350,000
Filed 2023-01-12 14:00
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-170,800
-140,000 vol
$1.22 each 		245,000
Filed 2023-01-12 13:59
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-152,600
-140,000 vol
$1.09 each 		385,000
Filed 2023-01-12 13:58
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-114,800
-140,000 vol
$0.82 each 		525,000
Filed 2023-01-12 13:57
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Howling, Kenneth George
5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-46,000
-200,000 vol
$0.23 each 		150,000
Filed 2023-01-12 13:54
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-170,800
-140,000 vol
$1.22 each 		245,000
Filed 2023-01-12 13:53
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-140,000
-140,000 vol
$1.00 each 		385,000
Filed 2023-01-12 13:51
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-170,800
-140,000 vol
$1.22 each 		116,300
Filed 2023-01-12 13:50
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-152,600
-140,000 vol
$1.09 each 		256,300
Filed 2023-01-12 13:49
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-77,000
-140,000 vol
$0.55 each 		396,300
Filed 2023-01-12 13:48
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-191,070
-173,700 vol
$1.10 each 		536,300
Filed 2023-01-12 13:45
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Golan, Yoav
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-244,000
-200,000 vol
$1.22 each 		200,000
Filed 2023-01-12 13:44
Tx date 2023-01-04 		$APLI
Appili Therapeutics Inc. 		Golan, Yoav
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase 		$-218,000
-200,000 vol
$1.09 each 		400,000
Filed 2022-06-10 16:38
Tx date 2022-06-10 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
55 - Expiration of warrants
-280,777 vol 		1,318,254
Filed 2022-06-10 16:35
Tx date 2022-06-10 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
55 - Expiration of warrants
-280,777 vol 		1,318,254
Filed 2022-05-26 14:35
Tx date 2022-05-26 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
46 - Compensation for services
+1,189,580 vol 		1,599,031
Filed 2022-05-26 14:32
Tx date 2022-05-26 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
46 - Compensation for services
+1,189,580 vol 		1,599,031
Filed 2022-05-26 14:26
Tx date 2022-02-20 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
55 - Expiration of warrants
-256,545 vol 		409,451
Filed 2022-05-26 14:22
Tx date 2022-02-20 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
55 - Expiration of warrants
-256,545 vol 		409,451
Filed 2021-12-13 14:05
Tx date 2021-12-08 		$APLI
Appili Therapeutics Inc. 		Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$31,850
+245,000 vol
$0.13 each 		525,000
Filed 2021-12-13 14:02
Tx date 2021-12-08 		$APLI
Appili Therapeutics Inc. 		Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$31,850
+245,000 vol
$0.13 each 		665,000
Filed 2021-12-13 14:01
Tx date 2021-12-08 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$31,850
+245,000 vol
$0.13 each 		710,000
Filed 2021-12-13 13:57
Tx date 2021-12-08 		$APLI
Appili Therapeutics Inc. 		Mortimer, Ian Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$31,850
+245,000 vol
$0.13 each 		710,000
Filed 2021-12-13 13:55
Tx date 2021-12-08 		$APLI
Appili Therapeutics Inc. 		Cilla, Donald
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$45,500
+350,000 vol
$0.13 each 		750,000
Filed 2021-12-13 13:53
Tx date 2021-12-08 		$APLI
Appili Therapeutics Inc. 		Golan, Yoav
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$26,000
+200,000 vol
$0.13 each 		600,000
Filed 2021-12-10 20:12
Tx date 2021-12-08 		$APLI
Appili Therapeutics Inc. 		Howling, Kenneth George
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$19,500
+150,000 vol
$0.13 each 		350,000
Filed 2021-11-29 16:42
Tx date 2021-11-29 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-35,935.80
-237,200 vol
$0.1515 each 		5,301,101
Filed 2021-11-19 16:10
Tx date 2021-11-16 		$APLI
Appili Therapeutics Inc. 		Howling, Kenneth George
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		200,000
Filed 2021-11-19 16:08
Tx date 2021-11-15 		$APLI
Appili Therapeutics Inc. 		Howling, Kenneth George
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-18 10:34
Tx date 2021-10-15 		$APLI
Appili Therapeutics Inc. 		Vejvoda, Josef
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+140,000 vol 		140,000
Filed 2021-10-18 10:28
Tx date 2021-09-07 		$APLI
Appili Therapeutics Inc. 		Vejvoda, Josef
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-10-14 14:02
Tx date 2021-10-14 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
46 - Compensation for services
+128,674 vol 		665,996
Filed 2021-10-14 14:00
Tx date 2021-10-14 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
46 - Compensation for services
+128,674 vol 		665,996
Filed 2021-09-07 14:51
Tx date 2021-09-07 		$APLI
Appili Therapeutics Inc. 		Vejvoda, Josef
4 - Director of Issuer
Direct Ownership
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-07-09 17:52
Tx date 2021-07-08 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$330.00
+500 vol
$0.66 each 		5,538,301
Filed 2021-07-02 16:50
Tx date 2021-06-30 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$640.00
+1,000 vol
$0.64 each 		5,537,801
Filed 2021-06-25 16:42
Tx date 2021-06-21 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$26,050
+36,500 vol
$0.71 each 		5,536,801
Filed 2021-06-18 17:00
Tx date 2021-06-15 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$26,491
+35,000 vol
$0.76 each 		5,500,301
Filed 2021-05-21 16:53
Tx date 2021-05-19 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$33,519
+39,500 vol
$0.85 each 		5,465,301
Filed 2021-05-21 16:53
Tx date 2021-05-18 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$88,000
+100,000 vol
$0.88 each 		5,425,801
Filed 2021-05-09 11:57
Tx date 2021-05-07 		$APLI
Appili Therapeutics Inc. 		Balboni, Armand
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+500,000 vol 		1,718,000
Filed 2021-05-08 13:10
Tx date 2021-05-07 		$APLI
Appili Therapeutics Inc. 		Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$170,800
+140,000 vol
$1.22 each 		280,000
Filed 2021-05-08 13:04
Tx date 2021-05-07 		$APLI
Appili Therapeutics Inc. 		Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$170,800
+140,000 vol
$1.22 each 		420,000
Filed 2021-05-08 13:00
Tx date 2021-05-07 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$170,800
+140,000 vol
$1.22 each 		465,000
Filed 2021-05-08 12:57
Tx date 2021-05-07 		$APLI
Appili Therapeutics Inc. 		Mortimer, Ian Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$170,800
+140,000 vol
$1.22 each 		465,000
Filed 2021-05-08 12:52
Tx date 2021-05-07 		$APLI
Appili Therapeutics Inc. 		Stephens, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$366,000
+300,000 vol
$1.22 each 		710,000
Filed 2021-05-08 12:45
Tx date 2021-05-07 		$APLI
Appili Therapeutics Inc. 		Cilla, Donald
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$244,000
+200,000 vol
$1.22 each 		400,000
Filed 2021-05-08 12:41
Tx date 2021-05-07 		$APLI
Appili Therapeutics Inc. 		Golan, Yoav
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$244,000
+200,000 vol
$1.22 each 		400,000
Filed 2021-03-06 10:11
Tx date 2021-03-04 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$6,546
+6,500 vol
$1.01 each 		5,325,801
Filed 2021-03-06 10:11
Tx date 2021-03-03 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$4,935
+4,700 vol
$1.05 each 		5,319,301
Filed 2021-03-06 10:11
Tx date 2021-03-01 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-550.00
-500 vol
$1.10 each 		5,314,601
Filed 2021-02-26 17:05
Tx date 2021-02-26 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$4,180
+4,000 vol
$1.04 each 		5,315,101
Filed 2021-02-26 17:04
Tx date 2021-02-23 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$44,339
+41,300 vol
$1.07 each 		5,311,101
Filed 2021-02-26 17:04
Tx date 2021-02-22 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$38,083
+34,300 vol
$1.11 each 		5,269,801
Filed 2021-02-19 17:07
Tx date 2021-02-18 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-58,892.33
-46,900 vol
$1.26 each 		5,235,501
Filed 2021-02-19 17:06
Tx date 2021-02-17 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-101,880.90
-75,300 vol
$1.35 each 		5,282,401
Filed 2021-02-19 17:06
Tx date 2021-02-16 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-111,237.30
-83,700 vol
$1.33 each 		5,357,701
Filed 2021-02-12 18:57
Tx date 2021-02-12 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-21,120.84
-15,600 vol
$1.35 each 		5,441,401
Filed 2021-02-12 18:57
Tx date 2021-02-11 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-89,800.50
-65,500 vol
$1.37 each 		5,457,001
Filed 2021-02-12 18:57
Tx date 2021-02-10 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-443,229.60
-326,000 vol
$1.36 each 		5,522,501
Filed 2021-02-12 18:56
Tx date 2021-02-09 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-121,199.12
-95,200 vol
$1.27 each 		5,848,501
Filed 2021-02-12 18:55
Tx date 2021-02-08 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-94,521.85
-78,500 vol
$1.20 each 		5,943,701
Filed 2021-02-03 21:46
Tx date 2021-01-31 		$APLI
Appili Therapeutics Inc. 		Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$140,000
+140,000 vol
$1.00 each 		140,000
Filed 2021-02-03 21:44
Tx date 2021-01-31 		$APLI
Appili Therapeutics Inc. 		Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-03 21:43
Tx date 2021-01-31 		$APLI
Appili Therapeutics Inc. 		Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-03 21:41
Tx date 2021-02-01 		$APLI
Appili Therapeutics Inc. 		Stenzler, Rochelle
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-29 17:32
Tx date 2021-01-27 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$14,078
+14,100 vol
$1.00 each 		6,022,201
Filed 2021-01-29 17:31
Tx date 2021-01-26 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$10,043
+9,200 vol
$1.09 each 		6,008,101
Filed 2021-01-22 17:24
Tx date 2021-01-20 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,352
+1,200 vol
$1.13 each 		5,998,901
Filed 2021-01-15 17:04
Tx date 2021-01-15 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$30,238
+27,100 vol
$1.12 each 		5,997,701
Filed 2021-01-15 17:03
Tx date 2021-01-14 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$3,626
+3,300 vol
$1.10 each 		5,970,601
Filed 2021-01-15 17:03
Tx date 2021-01-13 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,996
+1,800 vol
$1.11 each 		5,967,301
Filed 2021-01-08 17:50
Tx date 2021-01-06 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$3,386
+3,000 vol
$1.13 each 		5,965,501
Filed 2021-01-08 17:49
Tx date 2021-01-05 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$570.00
+500 vol
$1.14 each 		5,962,501
Filed 2020-12-31 17:06
Tx date 2020-12-31 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$48,776
+40,800 vol
$1.20 each 		5,962,001
Filed 2020-12-31 17:05
Tx date 2020-12-30 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,950
+1,700 vol
$1.15 each 		5,921,201
Filed 2020-12-31 17:04
Tx date 2020-12-29 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$5,031
+4,400 vol
$1.14 each 		5,919,501
Filed 2020-12-25 10:02
Tx date 2020-12-24 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$4,669
+3,900 vol
$1.20 each 		5,915,101
Filed 2020-12-25 10:02
Tx date 2020-12-23 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$3,911
+3,200 vol
$1.22 each 		5,911,201
Filed 2020-12-25 10:02
Tx date 2020-12-21 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$41,828
+34,300 vol
$1.22 each 		5,908,001
Filed 2020-12-18 17:42
Tx date 2020-12-18 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$116,854
+91,200 vol
$1.28 each 		5,873,701
Filed 2020-12-18 17:41
Tx date 2020-12-17 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$98,266
+75,700 vol
$1.30 each 		5,782,501
Filed 2020-12-18 17:41
Tx date 2020-12-16 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$24,086
+18,300 vol
$1.32 each 		5,706,801
Filed 2020-12-18 17:41
Tx date 2020-12-15 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-8,071.79
-5,900 vol
$1.37 each 		5,688,501
Filed 2020-12-18 17:40
Tx date 2020-12-14 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-670.00
-500 vol
$1.34 each 		5,694,401
Filed 2020-12-11 17:55
Tx date 2020-12-09 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$3,820
+3,300 vol
$1.16 each 		5,694,901
Filed 2020-12-10 13:55
Tx date 2020-12-07 		$APLI
Appili Therapeutics Inc. 		Cilla, Donald
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$244,000
+200,000 vol
$1.22 each 		200,000
Filed 2020-12-10 13:53
Tx date 2020-11-01 		$APLI
Appili Therapeutics Inc. 		Cilla, Donald
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-11-27 17:28
Tx date 2020-11-26 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$6,530
+6,100 vol
$1.07 each 		5,691,601
Filed 2020-11-27 17:27
Tx date 2020-11-25 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,938
+1,800 vol
$1.08 each 		5,685,501
Filed 2020-11-27 17:27
Tx date 2020-11-24 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$8,767
+8,000 vol
$1.10 each 		5,683,701
Filed 2020-11-27 17:27
Tx date 2020-11-23 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,216
+1,100 vol
$1.11 each 		5,675,701
Filed 2020-11-24 12:13
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		8,491
Filed 2020-11-24 12:11
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		8,491
Filed 2020-11-24 11:05
Tx date 2020-11-20 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
54 - Exercise of warrants
-2,200 vol 		537,322
Filed 2020-11-24 10:53
Tx date 2020-11-20 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
54 - Exercise of warrants
-2,200 vol 		537,322
Filed 2020-11-20 17:02
Tx date 2020-11-18 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,095
+1,000 vol
$1.09 each 		5,674,601
Filed 2020-11-20 17:02
Tx date 2020-11-17 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,070
+1,000 vol
$1.07 each 		5,673,601
Filed 2020-11-20 17:02
Tx date 2020-11-16 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$4,708
+4,300 vol
$1.10 each 		5,672,601
Filed 2020-11-13 16:48
Tx date 2020-11-09 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$4,988
+4,300 vol
$1.16 each 		5,668,301
Filed 2020-11-06 16:58
Tx date 2020-11-06 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-29,231.76
-18,600 vol
$1.57 each 		5,664,001
Filed 2020-10-30 16:58
Tx date 2020-10-30 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-34,913.67
-24,100 vol
$1.45 each 		5,682,601
Filed 2020-10-30 16:57
Tx date 2020-10-29 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-4,006.93
-2,900 vol
$1.38 each 		5,706,701
Filed 2020-10-23 16:41
Tx date 2020-10-23 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$2,041
+1,500 vol
$1.36 each 		5,709,601
Filed 2020-10-23 16:40
Tx date 2020-10-22 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$7,506
+5,500 vol
$1.36 each 		5,708,101
Filed 2020-10-09 16:37
Tx date 2020-10-05 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-14,107.28
-9,200 vol
$1.53 each 		5,702,601
Filed 2020-10-02 16:58
Tx date 2020-10-02 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-6,565.05
-4,500 vol
$1.46 each 		5,711,801
Filed 2020-10-02 16:58
Tx date 2020-10-01 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-75,492.34
-53,900 vol
$1.40 each 		5,716,301
Filed 2020-10-02 16:57
Tx date 2020-09-30 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-8,151
-6,000 vol
$1.36 each 		5,770,201
Filed 2020-09-25 16:58
Tx date 2020-09-25 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-55,623.75
-45,500 vol
$1.22 each 		5,776,201
Filed 2020-09-25 16:57
Tx date 2020-09-22 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-2,400
-2,000 vol
$1.20 each 		5,821,701
Filed 2020-09-18 19:54
Tx date 2020-09-16 		$APLI
Appili Therapeutics Inc. 		Golan, Yoav
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$218,000
+200,000 vol
$1.09 each 		200,000
Filed 2020-09-18 19:53
Tx date 2020-04-01 		$APLI
Appili Therapeutics Inc. 		Golan, Yoav
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-18 19:48
Tx date 2020-09-16 		$APLI
Appili Therapeutics Inc. 		Balboni, Armand
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		1,218,000
Filed 2020-09-18 19:45
Tx date 2020-09-16 		$APLI
Appili Therapeutics Inc. 		Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$152,600
+140,000 vol
$1.09 each 		280,000
Filed 2020-09-18 19:43
Tx date 2020-09-16 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$152,600
+140,000 vol
$1.09 each 		325,000
Filed 2020-09-18 19:41
Tx date 2020-09-16 		$APLI
Appili Therapeutics Inc. 		Mortimer, Ian Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$152,600
+140,000 vol
$1.09 each 		325,000
Filed 2020-09-18 19:34
Tx date 2020-09-16 		$APLI
Appili Therapeutics Inc. 		Stephens, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$109,000
+100,000 vol
$1.09 each 		410,000
Filed 2020-09-18 17:01
Tx date 2020-09-18 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-595.00
-500 vol
$1.19 each 		5,823,701
Filed 2020-08-28 16:59
Tx date 2020-08-28 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$6,155
+8,000 vol
$0.77 each 		5,824,201
Filed 2020-08-28 16:59
Tx date 2020-08-24 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$59,255
+69,500 vol
$0.85 each 		5,816,201
Filed 2020-08-23 19:24
Tx date 2020-08-21 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$27,054
+29,500 vol
$0.92 each 		5,746,701
Filed 2020-08-07 17:14
Tx date 2020-08-04 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$10,940
+12,000 vol
$0.91 each 		5,717,201
Filed 2020-08-01 10:29
Tx date 2020-07-31 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$7,910
+8,500 vol
$0.93 each 		5,705,201
Filed 2020-08-01 10:28
Tx date 2020-07-29 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,380
+1,500 vol
$0.92 each 		5,696,701
Filed 2020-07-24 17:08
Tx date 2020-07-24 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,459
+1,500 vol
$0.97 each 		5,695,201
Filed 2020-07-24 17:07
Tx date 2020-07-23 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$24,025
+24,300 vol
$0.99 each 		5,693,701
Filed 2020-07-24 17:07
Tx date 2020-07-21 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$30,142
+31,200 vol
$0.97 each 		5,669,401
Filed 2020-07-24 17:06
Tx date 2020-07-20 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$16,683
+16,300 vol
$1.02 each 		5,638,201
Filed 2020-07-17 17:01
Tx date 2020-07-17 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$948.96
+900 vol
$1.05 each 		5,621,901
Filed 2020-07-17 17:01
Tx date 2020-07-16 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$5,406
+5,100 vol
$1.06 each 		5,621,001
Filed 2020-07-03 19:57
Tx date 2020-06-30 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$455.00
+500 vol
$0.91 each 		5,615,901
Filed 2020-06-12 17:41
Tx date 2020-06-10 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
+692,642 vol 		2,020,142
Filed 2020-06-12 17:33
Tx date 2020-06-10 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
15 - Acquisition or disposition under a prospectus 		$1,662,340
+1,385,284 vol
$1.20 each 		5,615,401
Filed 2020-06-12 17:31
Tx date 2020-06-04 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$28,577
+25,000 vol
$1.14 each 		4,230,117
Filed 2020-06-10 12:04
Tx date 2020-06-10 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
15 - Acquisition or disposition under a prospectus
+280,777 vol 		539,522
Filed 2020-06-10 11:55
Tx date 2020-06-10 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
15 - Acquisition or disposition under a prospectus
+280,777 vol 		539,522
Filed 2020-05-29 17:02
Tx date 2020-05-29 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$4,285
+2,800 vol
$1.53 each 		4,205,117
Filed 2020-05-29 17:02
Tx date 2020-05-28 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,856
+1,200 vol
$1.55 each 		4,202,317
Filed 2020-05-29 17:01
Tx date 2020-05-27 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$72,763
+47,200 vol
$1.54 each 		4,201,117
Filed 2020-05-29 17:01
Tx date 2020-05-26 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$3,510
+2,200 vol
$1.60 each 		4,153,917
Filed 2020-05-22 17:04
Tx date 2020-05-21 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,849
+1,200 vol
$1.54 each 		4,151,717
Filed 2020-05-15 17:03
Tx date 2020-05-11 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$34,696
+24,000 vol
$1.45 each 		4,150,517
Filed 2020-05-08 17:47
Tx date 2020-05-08 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$14,116
+9,600 vol
$1.47 each 		4,126,517
Filed 2020-05-08 17:47
Tx date 2020-05-07 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$18,577
+12,400 vol
$1.50 each 		4,116,917
Filed 2020-05-08 17:46
Tx date 2020-05-05 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$6,000
+4,000 vol
$1.50 each 		4,104,517
Filed 2020-05-02 16:19
Tx date 2020-04-30 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$51,867
+35,800 vol
$1.45 each 		4,100,517
Filed 2020-05-02 16:18
Tx date 2020-04-29 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-9,018
-6,000 vol
$1.50 each 		4,064,717
Filed 2020-05-02 16:18
Tx date 2020-04-28 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-21,270.24
-14,400 vol
$1.48 each 		4,070,717
Filed 2020-04-20 18:26
Tx date 2020-04-17 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-315.00
-300 vol
$1.05 each 		4,085,117
Filed 2020-04-20 18:26
Tx date 2020-04-16 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-3,385.92
-3,200 vol
$1.06 each 		4,085,417
Filed 2020-04-20 18:25
Tx date 2020-04-14 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-2,535
-2,500 vol
$1.01 each 		4,088,617
Filed 2020-04-13 17:12
Tx date 2020-04-09 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$3,360
+3,500 vol
$0.96 each 		4,091,117
Filed 2020-04-03 17:17
Tx date 2020-04-03 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-8,670
-10,000 vol
$0.87 each 		4,087,617
Filed 2020-04-03 17:17
Tx date 2020-03-31 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-6,800
-10,000 vol
$0.68 each 		4,097,617
Filed 2020-03-27 16:59
Tx date 2020-03-25 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-20,484.80
-28,000 vol
$0.73 each 		4,107,617
Filed 2020-03-21 13:22
Tx date 2020-03-20 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-670.00
-1,000 vol
$0.67 each 		4,135,617
Filed 2020-03-21 13:21
Tx date 2020-03-19 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-2,970
-4,500 vol
$0.66 each 		4,136,617
Filed 2020-03-16 17:20
Tx date 2020-03-13 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$35,091
+63,000 vol
$0.56 each 		4,141,117
Filed 2020-03-16 17:20
Tx date 2020-03-12 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$27,189
+44,500 vol
$0.61 each 		4,078,117
Filed 2020-03-16 17:19
Tx date 2020-03-11 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-6,237
-9,000 vol
$0.69 each 		4,033,617
Filed 2020-03-16 17:19
Tx date 2020-03-11 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$68,250
+105,000 vol
$0.65 each 		4,042,617
Filed 2020-03-16 17:17
Tx date 2020-03-10 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$-1,400
-2,000 vol
$0.70 each 		3,937,617
Filed 2020-03-02 16:46
Tx date 2020-02-28 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$21,804
+31,500 vol
$0.69 each 		3,939,617
Filed 2020-03-02 16:45
Tx date 2020-02-26 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$5,950
+8,500 vol
$0.70 each 		3,908,117
Filed 2020-03-02 16:45
Tx date 2020-02-25 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$3,449
+5,000 vol
$0.69 each 		3,899,617
Filed 2020-03-02 16:44
Tx date 2020-02-24 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
10 - Acquisition or disposition in the public market 		$1,900
+2,500 vol
$0.76 each 		3,894,617
Filed 2020-02-22 14:37
Tx date 2020-02-20 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		1,327,500
Filed 2020-02-22 14:36
Tx date 2020-02-20 		$APLI
Appili Therapeutics Inc. 		The K2 Principal Fund L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		3,892,117
Filed 2020-02-20 12:16
Tx date 2020-02-20 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
15 - Acquisition or disposition under a prospectus
+256,545 vol 		258,745
Filed 2020-02-20 11:50
Tx date 2020-02-20 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
15 - Acquisition or disposition under a prospectus
+256,545 vol 		258,745
Filed 2020-02-05 15:59
Tx date 2020-01-24 		$APLI
Appili Therapeutics Inc. 		Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$114,099
+140,000 vol
$0.81 each 		140,000
Filed 2020-02-05 15:55
Tx date 2020-01-24 		$APLI
Appili Therapeutics Inc. 		Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-06 13:33
Tx date 2019-12-02 		$APLI
Appili Therapeutics Inc. 		Balboni, Armand
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+1,000,000 vol 		1,018,000
Filed 2019-12-06 10:46
Tx date 2019-12-02 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$77,000
+140,000 vol
$0.55 each 		185,000
Filed 2019-12-06 10:44
Tx date 2019-12-02 		$APLI
Appili Therapeutics Inc. 		Mortimer, Ian Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$77,000
+140,000 vol
$0.55 each 		185,000
Filed 2019-12-06 10:41
Tx date 2019-12-02 		$APLI
Appili Therapeutics Inc. 		Stephens, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$110,000
+200,000 vol
$0.55 each 		310,000
Filed 2019-06-22 16:04
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton & Co. Inc. (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		14,350,120
Filed 2019-06-22 16:01
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report 		2,200
Filed 2019-06-22 15:51
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton & Co. Inc. (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report 		2,200
Filed 2019-06-22 15:47
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Securities Inc. (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		14,350,120
Filed 2019-06-18 15:22
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Development Corporation (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-18 15:12
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Development Corporation (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-21 13:59
Tx date 2017-01-01 		$APLI
Appili Therapeutics Inc. 		Nicolle, Stephen
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		45,000
Filed 2019-06-21 13:55
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Matkovits, Theresa
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		45,000
Filed 2019-06-20 14:23
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Balboni, Armand
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		18,000
Filed 2019-06-20 10:43
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Stephens, Kimberly
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		110,000
Filed 2019-06-20 10:42
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Stephens, Kimberly
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		57,436
Filed 2019-06-20 10:34
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Sullivan, Kevin
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		355,000
Filed 2019-06-20 10:33
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Sullivan, Kevin
5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		14,243
Filed 2019-06-20 10:32
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Sullivan, Kevin
5 - Senior Officer of Issuer
Holder: Crimson Research Inc. (Indirect Ownership)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		772,000
Filed 2019-06-19 12:33
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Mortimer, Ian Charles
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		45,000
Filed 2019-06-18 15:22
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Burton, Jolyon
6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Development Corporation (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		13,896,000
Filed 2019-06-18 15:12
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Bloom, Brian Matthew
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Bloom Burton Development Corporation (Control or Direction)
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		13,896,000
Filed 2019-06-18 15:01
Tx date 2019-06-13 		$APLI
Appili Therapeutics Inc. 		Bloom Burton Development Corporation
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares Class A Common Shares
00 - Opening Balance-Initial SEDI Report 		13,896,000